In a report released today, Peter Welford from Jefferies maintained a Buy rating on Sanofi (SNYNF – Research Report), with a price target ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Sanofi (SNYNF – Research Report) and ...

Sanofi said on Monday it had entered exclusive talks for the sale of a 50% controlling stake in its consumer health business ...

France's CGT and CFDT unions have called on workers at pharma company Sanofi to strike from Thursday to show their protest ...

France will take a stake in Sanofi's Opella through the Public Investment Bank (BPI), finance minister Antoine Armand said on ...

The French drugmaker will invest 300 million euros into a new entity that will develop lead isotope-based therapies for ...

This month on pharmaphorum, we explore the history of French pharmaceutical company Sanofi, which was created through many partnerships and acquisitions over a period of 100 years. Sanofi is one ...

The proposal from PAI Partners, challenging a US bidder, is the latest twist in a battle to win a 50% stake in Opella, the ...

The U.S. Food and Drug Administration has put on hold a trial of Novavax's COVID-influenza and its standalone flu vaccines ...

Analysing the top 10 tech company logos, we can understand the art and science behind creating visual identities that stand out from the crowd. This article dives into the nuances of visual identity, ...

The approval will give Sanofi its first opportunity get a return on its investment in Bioverativ, a company it acquired for $11.6 billion in 2018, after its first attempt to seek approval from the ...

Pursuant to the Scheme becoming effective the Consumer Healthcare Division (CHC) business of Sanofi India Limited (SIL) got demerged into the Company as a going concern through the Scheme of ...